Medical management of neuropathy from BV + AVD
| Medication or therapy . | Patients with neuropathy (n = 123), n (%) . |
|---|---|
| Gabapentin | 53 (43%) |
| Duloxetine or other SNRI | 12 (10%) |
| Vitamin B complex | 12 (10%) |
| Pregabalin | 8 (7%) |
| Exercise therapy | 5 (4%) |
| Alpha lipoic acid | 4 (3%) |
| Acupuncture | 5 (4%) |
| Amitryptiline or other TCA | 3 (2%) |
| Other | 7 (6%) |
| None | 48 (39%) |
| Medication or therapy . | Patients with neuropathy (n = 123), n (%) . |
|---|---|
| Gabapentin | 53 (43%) |
| Duloxetine or other SNRI | 12 (10%) |
| Vitamin B complex | 12 (10%) |
| Pregabalin | 8 (7%) |
| Exercise therapy | 5 (4%) |
| Alpha lipoic acid | 4 (3%) |
| Acupuncture | 5 (4%) |
| Amitryptiline or other TCA | 3 (2%) |
| Other | 7 (6%) |
| None | 48 (39%) |
Numbers may not sum to 100% as in some cases, patients were prescribed more than 1 medication. SNRI, serotonin and norepinephrine reuptake inhibitor; TCA, tricyclic antidepressant.